Childhood leukemia incidence in Britain, 1974-2000: time trends and possible relation to influenza epidemics

Journal of the National Cancer Institute
Mary E KrollMichael F G Murphy

Abstract

Time trends in incidence of disease may cast light on etiology. We investigated time trends in childhood leukemia by using Poisson regression methods to analyze data from the National Registry of Childhood Tumours, a long-standing high-quality registry that covers the whole childhood population of Britain. During 1974-2000, the average annual percentage change in rate (AAC) of childhood acute lymphoblastic leukemia (ALL) in Britain was 0.7% (95% confidence interval [CI] = 0.4 to 1.0). This increase was apparently driven by the "common" subtype (expressing the CD10 antigen) of precursor B-cell ALL, for which the estimated AAC during 1980-1996 was 1.4% (95% CI = 0.8 to 2.0). There was no statistically significant time trend in other subtypes of ALL combined (1980-1996) or in acute myeloid leukemia (1974-2000). Small peaks in incidence of ALL in 1976 and 1990 coincided with years immediately following influenza epidemics. These results are consistent with hypotheses that some childhood leukemia may be triggered by infection occurring close to the time of diagnosis of leukemia, particularly in conditions of low herd immunity, and raise the possibility that contact with influenza shortly before the diagnosis of leukemia may sometime...Continue Reading

References

Jan 1, 1975·American Journal of Epidemiology·D F AustinB E Henderson
Mar 1, 1976·American Journal of Epidemiology·N J Vianna, A K Polan
May 27, 1972·British Medical Journal·J Fedrick, E D Alberman
Mar 24, 1973·British Medical Journal·J F BithellP D Gorbach
Jan 1, 1973·International Journal of Epidemiology·O P HeinonenD Slone
Nov 1, 1974·American Journal of Epidemiology·V L Randolph, C W Heath
Oct 1, 1974·Journal of the National Cancer Institute·M G CurnenL R Turgeon
Dec 16, 1972·British Medical Journal·I Leck, J K Steward
Nov 3, 1973·British Medical Journal·T HakulinenL Saxén
Feb 1, 1997·Lancet·M F Greaves
Jul 29, 1999·British Journal of Cancer·J D DockertyM E Lewis
Sep 13, 2001·Cancer Causes & Control : CCC·E PetridouUNKNOWN Childhood Haematologists-Oncologists Group
Mar 18, 2003·International Journal of Cancer. Journal International Du Cancer·Tibor A NyariLouise Parker
Jul 1, 2004·British Journal of Cancer·L Kinlen, R Doll
Oct 20, 2004·British Journal of Haematology·Richard J Q McNally, Tim O B Eden

❮ Previous
Next ❯

Citations

Mar 26, 2013·Lancet·Hiroto InabaCharles G Mullighan
Jul 11, 2009·Environmental Health Perspectives·Mary H WardPatricia A Buffler
Jan 31, 2014·International Journal of Environmental Research and Public Health·Michael GoodmanDonald R Mattison
Feb 28, 2007·Journal of Epidemiology and Community Health·Benedetto Terracini, Milena Maria Maule
Apr 16, 2011·Environmental Health : a Global Access Science Source·Benedetto Terracini
Aug 22, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K Pritchard-JonesJ W W Coebergh
Dec 7, 2006·Journal of the National Cancer Institute·Richard J Q McNally, Tim O B Eden
Aug 23, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L YangN Sakamoto
Jan 10, 2017·Annals of Epidemiology·Todd P WhiteheadCatherine Metayer
Jan 16, 2018·Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology·Namita SharmaNisar A Bhat
May 26, 2006·Bioelectromagnetics·Leeka KheifetsSander Greenland
Aug 23, 2007·British Journal of Cancer·A Shah, M P Coleman
Oct 1, 2007·Proteomics. Clinical Applications·Silke HenrichRichard I Christopherson
Oct 11, 2008·International Journal of Cancer. Journal International Du Cancer·Richard J Q McNallyMichael F G Murphy
Jan 7, 2010·Pediatric Blood & Cancer·Ping-ping BaoWei Lu
May 16, 2013·Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews·Claudia ZaniFrancesco Donato
Aug 30, 2020·Pediatric Blood & Cancer·Mel Greaves
Nov 14, 2012·Expert Review of Hematology·Kate A O'NeillMichael F G Murphy
Aug 23, 2018·British Journal of Cancer·Gerald J DraperCharles A Stiller
Nov 21, 2020·Acta Paediatrica·Kjeld Schmiegelow
Jul 8, 2019·Cancer Epidemiology·Grit SommerUNKNOWN Swiss Paediatric Oncology Group (SPOG)
Jan 14, 2021·Molecular Biology Reports·Thiago Cezar FujitaMaria Angelica Ehara Watanabe
Apr 10, 2021·Leukemia·Mel GreavesAnthony Ford
Nov 17, 2012·Environmental Science & Technology·Guodong DingYing Tian
May 20, 2021·Blood·Julia HauerArndt Borkhardt
Dec 29, 2020·Journal of Pediatric Hematology/oncology·Yogindra PersaudJeffrey W Taub

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Related Papers

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Xiaomei MaJohn K Wiencke
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Andishe AttarbaschiMichael N Dworzak
© 2021 Meta ULC. All rights reserved